Empagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway

Aims. The cardiobenefits of empagliflozin are multidimensional, and some mechanisms are still unclear. The aim of the present study was to evaluate the effect of treatment with empagliflozin on biometric parameters and gene expression in the local cardiac RAS, oxidative stress, and endoplasmic retic...

Descripción completa

Detalles Bibliográficos
Autores principales: Cotrin, Juliana Cordovil, de Souza, Gabriel Santos Martins, Petito-da-Silva, Tamiris Ingrid, Cardoso, Luiz Eduardo Macedo, Souza-Mello, Vanessa, Barbosa-da-Silva, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789460/
https://www.ncbi.nlm.nih.gov/pubmed/35111238
http://dx.doi.org/10.1155/2022/8861911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789460/
https://www.ncbi.nlm.nih.gov/pubmed/35111238
http://dx.doi.org/10.1155/2022/8861911

Ejemplares similares